J. P. Hester - Concepedia

Concepedia

Author

J. P. Hester

The University of Texas MD Anderson Cancer Center

Also Known As

J Hester, J P Hester, J. Hester, J. P. HESTER, J. P. Hester, J.P. HESTER, J.P. Hester, JP Hester

51

Publications

1.9K

Citations

17

H-Index

34

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas System Anderson Hospital The University of Texas Health Science Center at Houston

JP

About

J. P. Hester is an author at The University of Texas MD Anderson Cancer Center specializing in hematology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	625
2	Health Sciences	3	3	93
3	Blood Transplantation	2	2	150
4	Cell Biology	1	1	14
5	Emergency Medicine	1	1	28

J. P. Hester

×

24

Publications

1.9K

Citations

17

H-Index

	Year	Citations
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Sergio Giralt, J. P. Hester, Yang O. Huh, Blood	1995	330
Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia P. Liu, HB Hsu, Paula Marlton, Blood	1994	161
Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study E. Anaissie, J. P. Hester, Stephen J. O’Brien, Leukemia GranulocyteTransfusion MedicineHematologyImmunologyClinical Mycology	1997	156
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy Elie G. Hanania, Richard E. Giles, J. J. Kavanagh, Proceedings of the National Academy of Sciences	1996	152
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED ADULT ACUTE LEUKÆMIA Karel A. Dicke, Gary Spitzer, L. J. Peters, The Lancet TransplantationMarrow TransplantationStem Cell TransplantationImmunologyHematology	1979	148
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma Raymond Alexanian, Donna Przepiorka, J. P. Hester, Blood	1993	122
Early myeloablative therapy for multiple myeloma R. Alexanian, J. P. Hester, Kay Delasalle, Blood	1994	117
Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia. Hagop M. Kantarjian, L Vellekoop, K. B. McCredie, Journal of Clinical Oncology Hematological MalignancySurgical OncologyOncologyMixed-phenotype Acute LeukemiaMalignant Blood Disorder	1985	107
Increased Granulocyte Collection with the Blood Cell Separator and the Addition of Etiocholanolone and Hydroxyethyl Starch K. B. McCredie, Emil J. Freireich, J. P. Hester, Transfusion ImmunologyTransplantation MedicinePathologyBlood CellTotal Number	1974	97
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma Raymond Alexanian, Donna Przepiorka, J. P. Hester, Blood	1993	87

Page 1